Medical Devices & Tech

OrSense

5 Golda Meir St, Weizmann Science Park, P.O.Box 4052
Nes Ziona, 74140 Israel
Phone
Fax
Click for website

Research Sector Medical Devices & Tech

Summary Description Non-invasive Measurement of Critical Blood Parameters and Blood Glucose Levels

Management Hamutal Anavi Russo, Chief Financial Officer; Dr. Ephraim Carlebach, Vice President Patient Monitoring; Alexander Finarov, Vice President Engineering; Ephraim Gabis, Vice President Operations; Hillegonda "Honny" Kipnis Groen, Vice President Sales (Europe); Aharon Weinstein, Vice President Research

Click here for Financial Data
Keywords: Glucose, diabetes, insulin, medical devices

Comment


Updated: Aug. 22, 2013


Description

OrSense is a medical device company that develops and commercializes patient monitoring solutions for non-invasive continuous measurements of hemoglobin, oxygen saturation, glucose and other blood par......view more

Products / Services

OrSense's flagship product is the CE approved NBM-200MP, which monitors and displays oxygen saturation of Hb (SpO2), low signal oximetry, SpO2, pulse rate, plethysmogram and hemoglobin, all non-invasi......view more

Technology / Differentiation

OrSenses patented technology, known as Occlusion Spectroscopy, uses a non-invasive optical measurement platform combined with a finger attached ring-shaped sensor probe. The pressure applied by the ...view more

Market / Customers

OrSense products target the hospital and home care markets. The hospital market, focused on acute and sub acute care departments, has an annual potential of over $3 billion. The home care market has a......view more


Status

OrSense's CE approved NBM-200MP is marketed in hospitals in Europe and Israel. OrSenses intellectual property portfolio consists of 51 granted patents with over 20 additional applications in proce...view more

RELATED COMPANIES



0000-00-00-8574